Biotech · Private company
GC Biopharma Corp
Track this companyFree. Adds GC Biopharma Corp to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- GC5107Phase 3 · Primary Immune DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- HM15421/GC1134APhase 2 · Fabry DisesaseClinicalTrials.gov · fetched Nov 12, 2026
- GC1130APhase 1 · Sanfilippo Syndrome Type AClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry DiseasePHASE1_PHASE2 · RECRUITING · started May 14, 2025ClinicalTrials.gov NCT06858397 · fetched Nov 12, 2026
- Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA)PHASE1 · ACTIVE_NOT_RECRUITING · started Nov 21, 2024ClinicalTrials.gov NCT06567769 · fetched Nov 12, 2026
- Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral ImmunodeficiencyPHASE3 · ACTIVE_NOT_RECRUITING · started Dec 21, 2020ClinicalTrials.gov NCT04565015 · fetched Nov 12, 2026